First Fiduciary Investment Counsel’s AbbVie ABBV Stock Holding History

First Fiduciary Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$469K	Buy	1,864 +700	+60%	+$151K	0.09%	60
2026 Q1	$253K	Sell	1,164 -3,000	-72%	-$665K	0.05%	62
2025 Q4	$951K	Sell	4,164 -200	-5%	-$45.6K	0.18%	44
2025 Q3	$1.01M	Hold	4,364	–	–	0.2%	43
2025 Q2	$810K	Buy	4,364 +150	+4%	+$27.9K	0.16%	45
2025 Q1	$883K	Hold	4,214	–	–	0.19%	46
2024 Q4	$749K	Hold	4,214	–	–	0.15%	48
2024 Q3	$832K	Hold	4,214	–	–	0.17%	49
2024 Q2	$723K	Hold	4,214	–	–	0.16%	49
2024 Q1	$767K	Sell	4,214 -100	-2%	-$17.2K	0.16%	49
2023 Q4	$669K	Buy	4,314 +131	+3%	+$19.1K	0.15%	47
2023 Q3	$624K	Buy	4,183 +375	+10%	+$55.1K	0.15%	46
2023 Q2	$513K	Hold	3,808	–	–	0.11%	49
2023 Q1	$607K	Hold	3,808	–	–	0.13%	50
2022 Q4	$615K	Buy	3,808 +308	+9%	+$47.2K	0.13%	49
2022 Q3	$470K	Hold	3,500	–	–	0.12%	50
2022 Q2	$536K	Hold	3,500	–	–	0.12%	52
2022 Q1	$567K	Hold	3,500	–	–	0.11%	52
2021 Q4	$474K	Hold	3,500	–	–	0.08%	53
2021 Q3	$378K	Hold	3,500	–	–	0.07%	54
2021 Q2	$394K	Hold	3,500	–	–	0.08%	54
2021 Q1	$379K	Hold	3,500	–	–	0.07%	55
2020 Q4	$375K	Hold	3,500	–	–	0.07%	50
2020 Q3	$307K	Hold	3,500	–	–	0.06%	53
2020 Q2	$344K	Hold	3,500	–	–	0.06%	54
2020 Q1	$267K	Hold	3,500	–	–	0.07%	54
2019 Q4	$310K	Buy	+3,500	New	+$291K	0.06%	55

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

First Fiduciary Investment Counsel's ABBV Position: Q2 2026 in Review

First Fiduciary Investment Counsel increased its AbbVie (ABBV) stake by 60% in Q2 2026, buying an estimated $151K and bringing the position to 1,864 shares worth $469K. The position accounts for 0.09% of the portfolio, ranked #60.

First Fiduciary Investment Counsel first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.01M in Q3 2025. 2,959 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

First Fiduciary Investment Counsel held 1,864 shares of AbbVie worth $469K as of Q2 2026.
First Fiduciary Investment Counsel bought 700 AbbVie shares in Q2 2026, an estimated $151K.
AbbVie made up 0.09% of First Fiduciary Investment Counsel's portfolio in Q2 2026, its #60 holding.
First Fiduciary Investment Counsel first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
First Fiduciary Investment Counsel's AbbVie position peaked at $1.01M in Q3 2025.
2,959 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First Fiduciary Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.